1.MCLEANAJ,COGGER V C,CHONG G C,etal.Age-related

Pseudocapillarization of the humanliver[J].JPathol,2003,200(1):

112-117.

2.LE-COUTEUR D G,COGGER V C,MCCUSKEY RS,etal.Age-

Related changes in the liver sinusoidalendothelium: a mechanism for dyslipidemia[J].Ann N YAcadSci,2007,1114(5):79-87.

3.CHO J Y,SUHK S,KWON C H,et al.Outcome ofdonors with a

Remnant liver volume of less than 35%after right hepatectomy[J]. I Liver Transpl,2006,12(2):201-206.

4.PEREZ M J,SUAREZ A,GOMEZ-CAPILLA J A,etal.Dietary

Nucleotide supplementation reducesthioacetamide-induced liver fibrosis in rats[J].JNutr,2002,132(4):652-657.

5.PROCKOP D J,KIVIRIKKO KI.Collagens:molecular biology,

Diseases，andpotentials for therapy[J]. Annu Rev Biochem, 1995, 64(7):403-434.

6.KOSSAKOWSKA A E,EDWARDS D R,LEES S,etal.Altered

Balance between matrix metalloproteinasesand their inhibitors in experimental biliary fibrosis[J].AmJPathol,1998,153(6):1895-1902.

7.MARUYAMA K,FEINMANL,FAINSILBERZ,etal.Mammalian

Collagenase increases in early liverdisease and decreases with cirrhosis[J].Life Sci,1982,30(16):1379-1384.

8.BENYON R C,IREDALE J P,GODDARD S,etal.Expression of

Tissue inhibitor of metalloproteinase 1and 2 is increased in fibrotic human liver[J].Gastroenterology,1996, 110(3):821-831.

9.HERBST H,WEGE T,MILANI S,et al.Tissueinhibitor of

metalloproteinase-1 and-2 RNA expressionin rat and human liver fibrosis[J].Am JPathol,1997,150(5):1647-1659.

10.HAND N J,MASTER Z R,LELJ,et al.Hepaticfunction is preserved In the absence of mature microRNAs[J]. Hepatology,2009,49(2):618-626.

11.OLIVIER C M,JIN A N,HARSHINI S,etal.Murine microRNAs

Implicated in liver functions andagingprocess[J].Mech Ageing Dev,2008,129(9):534-541.

12.KLOOSTERMAN W P,WIENHOLDS E,DE-BRUIJINE,et al.in

Situ detection of miRNAs in animal embryosusing LNA-modified oligonucleotide probes[J].Nat Meth,2006,3:27-29.

13.ZHU Q,SUN W,OKANO K,etal.Spongetransgenic mouse model

Reveals important roles for themicroRNA-183(miR-183)/96/182cluster in postmitotic photoreceptors of theretina[J].J Biol Chem,2011,286:31749-31760.

14.LI G R,LUNA C L,QIU J M.etal.Alterations in microRNA

Expression in stress-induced cellularsenescence[J]. Mech Ageing Dev,2009,130:731-741.

15.MOSKWA P,BUFFA F M,PANY,etal.miR-182mediated down

Regulation of BRCA1 impacts DNA repair andsensitivity to PARP inhibitors[J]. Mol Cell,2011,41(2):210-220.

16.RODRIGUEZ-GONZALEZ F G,SIEUWETS AM,SMID M,et al.

MicroRNA-30cexpression level is anindependent predictor of clinical benefit of endocrine therapy in advancedestrogen receptor positive breast cancer[J].Breast Cancer Res Treat,2011,127(1):43-51.

17.SUN Y,FANG R,LI C,etal.Hsa-mir-182suppresses lung tumori-Genesis through down regulation of RGS17expression in vitro[J].Biochemical and Biophysical Research Communications,2010,396 (2):501-507.

18.BARSHACK I,LITHWICK Y G,AFEKA,etal.MicroRNA

Expression differentiates between primarylung tumors and metastases to thelung[J].Pathology Research and Practice,2010,206(8):578-584.

19.SARVER A L,FRENCH A J,BORRALHO P M,etal.Human colon

Cancer profiles showd ifferential microRNAexpression depending onmismatch repair status and are characteristic ofundifferentiated proliferative states[J].BMC Cancer,2009,18(9):1-15.

20.SCHAEFER A,JUNG M,MOLLENKOPF H J,etal.Diagnostic

And prognostic implications of microRNAprofiling in prostate carcinoma[J].International Journal of Cancer,2010,126(5):1166-1176.

21.NAGARAJA A K,CREIGHTONCJ,YU Z,et al.Alink between

Mir 100 and FRAP1/mTOR in clear cellovarian cancer[J].Journal of Molecular Endocrinology, 2010,24(2):447-463.

22.MYATT S S,WANG J,MONTEIROL J,etal.Definition of

microRNAs that repress expression of thetumor suppressor gene FOXO1 in endometrial cancer[J].CancerResearch,2010,70(1):367-377.

23.PATRICK P.Interpretation andapplicability of microRNA data to the Context of Alzheimer’sandage-related diseases[J]. Aging(AlbanyNY), 2010,2(3):166-169.

24.LI W Q,LI Y M,TAO B B,et al.Downregulation of ABCG2

Expression in glioblastoma cancer stemcells with may decrease their chemoresistance[J].Med Sci Monit,2010,16(10):27-30.

25.MACLAUCHLAN S,SKOKOS E A,AGAH A,etal.Enhanced

Angiogenesis and reduced contraction inthrombospondin-2-null wounds is associated with increased levels of matrix   metalloproteinases-2   and-9,and soluble VEGF[J].JHistochem Cytochem,2009,57(4):301-313.

26.ANIKUMAR N,ANNIS D S,MOSHER D F,etal.Trimericassembly

Of the C-terminal region ofthrombospondin- 1 or thrombospondin-2 is necessary for cell spreading andfascin spike organisation[J]. J CellSci, 2002,115(Pt11):2357-2366.

27.慕永平,刘平,王磊,等.一贯煎影响CCl4大鼠肝硬化形成期肝组织基因表达谱的效应机制研究[J].世界科学技术:中医药现代化,2007,9:43-54.

28.CARL H H,BENGT W.Mechanism of actionand in vivo role of platelet-derived growth factor[J].PhysiolRev,1999,79(4):1283-1316.

29.SUNDARESAN S,VIJAYAGOPAL P,MILL S N,etal.Amouse

Model for nonalcoholicsteatohepatitis[J].J Nutr Biochem,2011,22(10):979-984.

30.MAGRO F,COSTA C.Long standing remissionof Crohn’sdisease Under imatinib therapy in patientswith Crohn’sdisease[J].Inflamm Bowel Dis,2006,12(11):1087-1089.